Recurrence Risk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The explanation is multifaceted.

A proteomics analysis revealed significant variations in protein expression and informative markers between African vs European prostate tumors.

Today, XtalPi, a leading global technology company in combining artificial intelligence (AI) and robotics to drive the discovery of groundbreaking medicine and innovative materials, announced the signing of a new agreement with CK Life Sciences, a member of the CK Hutchison Group. Expanding upon their existing partnership, the two companies will combine AI algorithms with anonymized clinical and biomarker data from cancer patients and healthy individuals in CK Life Sciences' data repository to j

Shay Elkins, a patient with triple negative breast cancer, shares her experience of relapse six months post-treatment, eventually leading her to seek a second opinion for her recurring symptoms. Dr. Noor Abuhadra discusses second-line treatment options for metastatic triple negative breast cancer, emphasizing newer therapies like antibody drug conjugates and PARP inhibitors, and highlights the evolving landscape that offers hope for patients.

New data highlights two novel proteomic tests that support treatment decision making in patients with non-small cell lung cancer : Expanded analysis of the VeriStrat® host immune classifier’s...